AI주식인사이트AI Stock Insight
C

서린바이오

038070KOSDAQ

43.5 / 100

Reference Date: 2026-09-08

Financial Score17.0 / 40
News Sentiment12.5 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Declined 5.5% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Sorin Bio operates as a 'Global Total Solutions Provider in Life Science & Healthcare', focusing on bio industry solutions, sanitation/sterilization services, AI-based bio analysis, and healthcare. Approximately 97.2% of its revenue comes from bio industry total solutions, which includes supplying raw materials, reagents, and equipment essential for biopharmaceutical development to research institutions and pharmaceutical companies.

Number of Employees

110people

Average Salary

60.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
68.81Industry Average 15.000.0Point

4.6x industry avg (risky)

PBR
0.46Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
0.66Industry Average 8.001.0Point

Well below industry avg

Debt Ratio
1.25Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼6.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼44.6% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 0.5% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (8%, downtrend)

Current 4,245Won52-week high 6,76652-week low 4,010
1-month return2.0Point

1m -5.46% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral전환가액의조정2026-08-13
  • Neutral반기보고서 (2026.06)2026-08-13